The relationship between Democrats and former President Trump can be characterized as mixing oil and water. However, there’s one agenda item in which their visions align. Both camps have, in one way or another, signaled support for applying price controls to prescription drugs accessed through Medicare Part D. The previous administration labeled the idea the “most favored nations” rule, while Democrats in Congress have included a version of the proposal in H.R.3.
To some degree, the alignment is refreshing; partisan entrenchment has characterized Washington for so long. But only one small problem: It’s a terrible idea.
Read the full op-ed in the Washington Times by Dr. Robert Campbell, a practicing physician in Pennsylvania, past president of the Pennsylvania Society of Anesthesiologists, and a member of the Job Creators Network.